# OnCo record acrivon-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/acrivon-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "acrivon-therapeutics" ;
  schema:name "Acrivon Therapeutics"@en ;
  schema:description "Acrivon Therapeutics uses a protein-activity test to pick the patients most likely to respond to its cancer drugs. Its lead drug blocks DNA damage checkpoint proteins and is being tested in womb and ovarian cancer."@en ;
  schema:url <https://onco.cc/companies/acrivon-therapeutics/>, <https://acrivon.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://acrivon.com/>, <https://acrivon.com/pipeline/>, <https://www.sec.gov/Archives/edgar/data/1781174/000119312522287727/d410573d8k.htm> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/ovarian/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/diagnostics/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/>, <https://onco.cc/technologies/proteomics/>, <https://onco.cc/technologies/companion-diagnostic/> ;
  onco:targets <https://onco.cc/targets/wee1/> ;
  onco:trials <https://onco.cc/trials/nct05548296/> .